Exact Mass: 472.094
Exact Mass Matches: 472.094
Found 156 metabolites which its exact mass value is equals to given mass value 472.094
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Clofazimine
A fat-soluble riminophenazine dye used for the treatment of leprosy. It has been used investigationally in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in AIDS patients. Clofazimine also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum. (From AMA Drug Evaluations Annual, 1993, p1619) J - Antiinfectives for systemic use > J04 - Antimycobacterials > J04B - Drugs for treatment of lepra > J04BA - Drugs for treatment of lepra D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007917 - Leprostatic Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C258 - Antibiotic D000893 - Anti-Inflammatory Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Compound WIN VIII
(-)-Epigallocatechin 3-(3-methyl-gallate)
(-)-Epigallocatechin 3-(3-methyl-gallate) is found in tea. (-)-Epigallocatechin 3-(3-methyl-gallate) is isolated from green tea (Thea sinensis) and oolong tea (Camellia sinensis). (-)-Epigallocatechin 3-(3-methyl-gallate) is a catechin. Epigallocatechin 3-O-(3-O-methyl)gallate is a natural product found in Limonium sinense with data available. Isolated from green tea (Thea sinensis) and oolong tea (Camellia sinensis). Epigallocatechin 3-(3-methylgallate) is found in tea. (-)-Epigallocatechin-3-(3''-O-methyl) gallate is a natural product isolated from the tea leaf, with strong antioxidative activity. (-)-Epigallocatechin-3-(3''-O-methyl) gallate has a strong cytotoxic activity for rat cancer cells[1]. (-)-Epigallocatechin-3-(3''-O-methyl) gallate is a natural product isolated from the tea leaf, with strong antioxidative activity. (-)-Epigallocatechin-3-(3''-O-methyl) gallate has a strong cytotoxic activity for rat cancer cells[1].
(-)-Epigallocatechin 3-(4-methyl-gallate)
(-)-Epigallocatechin 3-(4-methyl-gallate) is found in tea. (-)-Epigallocatechin 3-(4-methyl-gallate) is a constituent of oolong tea (Camellia sinensis). Constituent of oolong tea (Camellia sinensis). Epigallocatechin 3-(4-methylgallate) is found in tea.
4-O-Methyl-a-D-glucosyl-(1->2)-b-D-xylosyl-(1->4)-D-xylose
4-O-Methyl-a-D-glucosyl-(1->2)-b-D-xylosyl-(1->4)-D-xylose is found in cereals and cereal products. 4-O-Methyl-a-D-glucosyl-(1->2)-b-D-xylosyl-(1->4)-D-xylose is from oat hull hemicelluloses. From oat hull hemicelluloses. 4-O-Methyl-a-D-glucosyl-(1->2)-b-D-xylosyl-(1->4)-D-xylose is found in cereals and cereal products.
Bofumustine
1,4-Di[3-(3-isothiocyanatophenyl)thioureido]butane
MRS 2578 is a selective and potent P2Y6 receptor antagonist with IC50s of 37 nM (human) and 98 nM (rat). MRS 2578 exhibits insignificant activity at P2Y1, P2Y2, P2Y4, and P2Y11 receptors[1][2].
4-{[(3S)-3-{[(7-Methoxynaphthalen-2-yl)sulfonyl](methyl)amino}-2-oxopyrrolidin-1-yl]methyl}thiophene-2-carboximidamide
CDP-N-dimethylethanolamine
Cdp-n-dimethylethanolamine is soluble (in water) and a moderately acidic compound (based on its pKa). Cdp-n-dimethylethanolamine can be found in a number of food items such as leek, chestnut, garden onion, and cloudberry, which makes cdp-n-dimethylethanolamine a potential biomarker for the consumption of these food products.
Fumarprotocetraric acid
Formononetin 7-O- (6'-acetylglucoside)
Epigallocatechin 3-O-(3-O-methyl)gallate
(-)-Epigallocatechin-3-(3''-O-methyl) gallate is a natural product isolated from the tea leaf, with strong antioxidative activity. (-)-Epigallocatechin-3-(3''-O-methyl) gallate has a strong cytotoxic activity for rat cancer cells[1]. (-)-Epigallocatechin-3-(3''-O-methyl) gallate is a natural product isolated from the tea leaf, with strong antioxidative activity. (-)-Epigallocatechin-3-(3''-O-methyl) gallate has a strong cytotoxic activity for rat cancer cells[1].
1,6-Bis-O-[(2E)-3-(4-hydroxyphenyl)-2-propenoyl]-β-D-glucopyranose
4-(3-carboxyprop-2-enoyloxymethyl)-10-formyl-3,9-dihydroxy-1,7-dimethyl-6-oxobenzo[b][1,4]benzodioxepine-2-carboxylic acid
3-phenyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxymethyl]oxan-2-yl]oxyprop-2-enoic acid
4-O-(6-O-P-Coumaroyl-beta-D-glucopyranosyl)-P-coumaric acid
3-acetoxy-4-methoxy-5-O-(beta-L-rhamnopyranosyl)flavone|shamimarin
4-O-benzoylchrologenic acid methyl ester|mumeic acid-A methyl ester
Aesculetin-6-O-beta-D-apiofuranosyl-(1->6)-O-beta-glucopyranoside
5,7-dihydroxycoumarin 7-(6-O-beta-D-apiofuranosyl-beta-D-glucopyranoside)|5,7-dihydroxycoumarin 7-O-beta-D-apiofuranosyl-(1->6)-O-beta-D-glucopyranoside|7-[(6-O-D-apio-beta-D-furanosyl-beta-D-glucopyranosyl)oxy]-5-hydroxy-2H-1-benzopyran-2-one
3-carboxy-6-methoxy-1-(3,4-dihydroxyphenyl)-naphthalene-7-O-alpha-L-rhamnopyranoside|3-Carboxy-6-methoxy-1-(3,4-dihydroxyphenyl)-naphthalene-7-O-??-L-rhamnopyranoside
C24H24O10_2-({6-O-[(2E)-3-(4-Hydroxyphenyl)-2-propenoyl]-beta-D-glucopyranosyl}oxy)-3-phenylacrylic acid
clofazimine
J - Antiinfectives for systemic use > J04 - Antimycobacterials > J04B - Drugs for treatment of lepra > J04BA - Drugs for treatment of lepra D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007917 - Leprostatic Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C258 - Antibiotic D000893 - Anti-Inflammatory Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
[(4E)-7-acetyloxy-6-hydroxy-2-methyl-10-oxo-2,3,6,7,8,9-hexahydrooxecin-3-yl] (E)-but-2-enoate
[(4E)-7-acetyloxy-6-hydroxy-2-methyl-10-oxo-2,3,6,7,8,9-hexahydrooxecin-3-yl] (E)-but-2-enoate_major
[(4E)-7-acetyloxy-6-hydroxy-2-methyl-10-oxo-2,3,6,7,8,9-hexahydrooxecin-3-yl] (E)-but-2-enoate_96.6\\%
4-O-Methyl-a-D-glucosyl-(1->2)-b-D-xylosyl-(1->4)-D-xylose
Epigallocatechin 3-(4-methylgallate)
2-({6-O-[(2E)-3-(4-Hydroxyphenyl)-2-propenoyl]-?-D-glucopyranosyl}oxy)-3-phenylacrylic acid
1-(t-butyloxycarbonyl)-2-triphenylphosphoniumhydrazine bromide
L-732,138
L-732138 is a selective, potent and competitive neurokinin-1 (NK-1) receptor antagonist with an IC50 of 2.3 nM. L-732138 has 200-fold more potent in cloned human NK-1 receptors than cloned rat NK-1 receptors, and has > 1000-fold more potent than human NK-2 and NK-3 receptors. L-732138 can reduce hyperalgesia and has antitumor action[1][2].
sodium 1-amino-4-[(4-butylphenyl)amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate
1-(3,5-Di-O-benzoyl-2-deoxy-2-fluoro-beta-L-arabinofuranosyl)-5-fluoro-2,4(1H,3H)-pyrimidinedione
4-O-methylepigallocatechin-3-O-gallate
A natural product found in Parapiptadenia rigida.
(3R)-3-[3-(6-carbamimidoyl-1H-benzimidazol-2-yl)-5-(2-methoxyphenyl)-4-oxidophenyl]-4-hydroxy-4-oxobutanoate
3-Benzyl-3,6-bis(cysteinyl)-6-(hydroxymethyl)-diketopiperazine
(2R)-2-amino-3-[(2R,5R)-5-[(2R)-2-amino-2-carboxyethyl]sulfanyl-2-benzyl-5-(hydroxymethyl)-3,6-dioxopiperazin-2-yl]sulfanylpropanoic acid
4-(4-chlorophenyl)-N-[3-[(4-methoxyphenyl)sulfamoyl]phenyl]-4-oxobutanamide
3-(4-methoxyphenyl)-1-phenyl-N-[(pyridine-4-carbonylamino)carbamothioyl]pyrazole-4-carboxamide
2-acetamido-3-(1H-indol-3-yl)propanoic acid [3,5-bis(trifluoromethyl)phenyl]methyl ester
2-[[3-cyano-6-(4-methoxyphenyl)-4-phenyl-2-pyridinyl]thio]-N-(5-methyl-2-thiazolyl)acetamide
5-[1-(2,4-dichlorobenzoyl)piperidin-4-yl]-3-(2-furylmethyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-ol
(1S,4S)-2-(2,6-difluorophenyl)sulfonyl-5-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2,5-diazabicyclo[2.2.1]heptane
2-[(2R,4aR,12aR)-8-[[(3-chlorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
[(1R,2aR,8bR)-2-[(2-chlorophenyl)methyl]-4-(4-fluorophenyl)sulfonyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-1-yl]methanol
[(1S,2aS,8bS)-2-[(2-chlorophenyl)methyl]-4-(4-fluorophenyl)sulfonyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-1-yl]methanol
2-[(2S,4aR,12aR)-8-[[(3-chlorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
2-[(2S,4aR,12aS)-8-[[(3-chlorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
2-[(2S,4aS,12aR)-8-[[(3-chlorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
[(2S,3S)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4-dihydroxy-5-methoxybenzoate
[(1S,2aR,8bR)-2-[(2-chlorophenyl)methyl]-4-(4-fluorophenyl)sulfonyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-1-yl]methanol
[(1R,2aS,8bS)-2-[(2-chlorophenyl)methyl]-4-(4-fluorophenyl)sulfonyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-1-yl]methanol
2-[(2R,4aS,12aR)-8-[[(3-chlorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
2-[(2R,4aR,12aS)-8-[[(3-chlorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
2-[(2S,4aS,12aS)-8-[[(3-chlorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
alpha-Kdo-(2->8)-alpha-7-O-Me-Kdo
A disaccharide derivative consisting of a 3-deoxy-alpha-D-manno-oct-2-ulopyranonosyl residue and a 3-deoxy-7-O-methyl-alpha-D-manno-oct-2-ulopyranonosyl joined via an alpha-(2->8)-linkage.
5-(5-(2,6-Dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole
2-{2-[1-(1,8-dihydroxy-2-methyl-9,10-dioxophenanthren-3-yl)-1-oxobutan-2-ylidene]hydrazin-1-yl}benzoic acid
methyl 6a,7,10a,12-tetrahydroxy-3,8-dimethoxy-1-methyl-6,10,11-trioxo-7h-tetracene-2-carboxylate
7-{[(3-carboxyprop-2-enoyl)oxy]methyl}-15-formyl-6,14-dihydroxy-4,12-dimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaene-5-carboxylic acid
(10r,11r,15s)-15-hydroxy-12-oxo-10-(3,4,5-trimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-11-yl acetate
5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4-dihydroxy-5-methoxybenzoate
2-{[6-(3,7-dimethylocta-2,6-dien-1-yl)-1,1,5,8-tetraoxo-3,4-dihydro-2h-1λ⁶,4-benzothiazin-7-yl]amino}ethanesulfonic acid
(2r,3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-5,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate
8,9-dihydroxy-15-(2-hydroxybutanoyl)-7-methoxy-6,18-dimethyl-3,5,19-trioxapentacyclo[11.6.1.0²,¹⁰.0⁴,⁹.0¹⁶,²⁰]icosa-1(20),2(10),12,15,17-pentaene-11,14-dione
(10s,11s,15r)-15-hydroxy-12-oxo-10-(3,4,5-trimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-11-yl acetate
4-(3,4-dihydroxyphenyl)-7-methoxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]naphthalene-2-carboxylic acid
2-(acetyloxy)-4',5,6-trihydroxy-4-(4-hydroxyphenyl)-[1,1'-biphenyl]-3-yl benzoate
3-carboxy-6-methoxy-1-(3',4'-dihydroxyphenyl)-naphthalene-7-o-α-l-rhamnopyranoside
{"Ingredient_id": "HBIN008379","Ingredient_name": "3-carboxy-6-methoxy-1-(3',4'-dihydroxyphenyl)-naphthalene-7-o-\u03b1-l-rhamnopyranoside","Alias": "NA","Ingredient_formula": "C24H24O10","Ingredient_Smile": "CC1C(C(C(C(O1)OC2=CC3=C(C=C(C=C3C=C2OC)C(=O)O)C4=CC(=C(C=C4)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3177","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}